Effectiveness of visual management health education in preventing venous thromboembolism in patients with complete occlusion of chronic coronary arteries

Abstract Objective Exploring the effectiveness of visually managed health education in reducing the risk of venous thromboembolism in patients with complete occlusion of chronic coronary arteries. Methods In this study, 100 patients with chronic total occlusion of coronary arteries and undergoing percutaneous coronary intervention (PCI) in cardiovascular medicine were included and divided into a test group and a control group with 50 patients in each group. Patients in the test group received health education based on visualization management, while patients in the control group received conventional health education. Relevant data were collected for further comparison. Statistical analysis was performed using SPSS and t-test and χ 2 test were used to analyze the differences. Results After intervention, there were higher levels of antithrombin III (AT3) and activated partial prothrombin time (APTT), while lower levels of D-dimer (D-D), fibrinogen degradation product (FDP), fibrinogen (FBG), and thrombin time (TT) in the test group than those before intervention. The control group showed decreased AT3 and APTT, while increased D-D, FDP,TT and FBG levels (P < 0.05). After intervention, the levels of AT3 and APTT in the test group were higher than those in the control group, while the levels of D-D, FDP, FBG, and TT were lower than those in the latter control group (P < 0.05). Furthermore, both groups of patients showed a decrease in Padua scores and an increase in prevention cognition scores after intervention (P < 0.05). After intervention, the Padua score of the test group was lower than that of the control group (P < 0.05). The test group had higher compliance score (P < 0.001) and satisfaction (P < 0.001). Conclusion Visual management health education can effectively improve the effect of health education, increase patients' awareness, compliance and satisfaction with VTE prevention, reduce the risk of lower limb VTE, and improve the coagulation function of CTO patients during PCI.